B, H., J, W., J, L., S, L., & H, L. (2020). Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility. Dove Medical Press.
Cita Chicago Style (17a ed.)B, Hu, Wang J, Li J, Li S, y Li H. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility. Dove Medical Press, 2020.
Cita MLA (8a ed.)B, Hu, et al. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility. Dove Medical Press, 2020.
Precaución: Estas citas no son 100% exactas.